NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,155 | -2.6% | 712 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,290 | +7.2% | 712 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,934 | -32.6% | 712 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $7,319 | -43.7% | 712 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $13,000 | -64.9% | 712 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $37,000 | -28.8% | 712 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $52,000 | -49.0% | 712 | 0.0% | 0.01% | -46.2% |
| Q4 2021 | $102,000 | -43.0% | 712 | -17.4% | 0.01% | -45.8% |
| Q3 2021 | $179,000 | -2.2% | 862 | 0.0% | 0.02% | -4.0% |
| Q2 2021 | $183,000 | +41.9% | 862 | +21.1% | 0.02% | +31.6% |
| Q1 2021 | $129,000 | +63.3% | 712 | 0.0% | 0.02% | +46.2% |
| Q4 2020 | $79,000 | +83.7% | 712 | +80.3% | 0.01% | +62.5% |
| Q3 2020 | $43,000 | +230.8% | 395 | +163.3% | 0.01% | +166.7% |
| Q2 2020 | $13,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |